[1]

Crasto W, Patel V, Davies MJ, Khunti K. 2021. Prevention of microvascular complications of diabetes. Endocrinology and Metabolism Clinics of North America 50:431−455

doi: 10.1016/j.ecl.2021.05.005
[2]

Vujosevic S, Aldington SJ, Silva P, Hernández C, Scanlon P, Peto T, et al. 2020. Screening for diabetic retinopathy: new perspectives and challenges. The Lancet Diabetes & Endocrinology 8:337−347

doi: 10.1016/S2213-8587(19)30411-5
[3]

Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. 2021. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. Journal of Diabetes Investigation 12:1322−1325

doi: 10.1111/jdi.13480
[4]

Li H, Liu X, Zhong H, Fang J, Li X, et al. 2023. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmology 23:372

doi: 10.1186/s12886-023-03118-6
[5]

Zhu JY, Yao W, Ni XS, Yao MD, Bai W, et al. 2023. Hyperglycemia-regulated tRNA-derived fragment tRF-3001a propels neurovascular dysfunction in diabetic mice. Cell Reports Medicine 4:101209

doi: 10.1016/j.xcrm.2023.101209
[6]

Dharmarajan S, Carrillo C, Qi Z, Wilson JM, Baucum AJ, et al. 2023. Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy. Diabetologia 66:2170−2185

doi: 10.1007/s00125-023-05995-4
[7]

Lei Y, Liu Q, Chen B, Wu F, Li Y, et al. 2024. Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nature Communications 15:9334

doi: 10.1038/s41467-024-53601-x
[8]

Simó R, Simó-Servat O, Bogdanov P, Hernández C. 2022. Diabetic retinopathy: role of neurodegeneration and therapeutic perspectives. Asia-Pacific Journal of Ophthalmology 11:160−167

doi: 10.1097/APO.0000000000000510
[9]

Yıldızhan K, Bayir MH, Huyut Z, Altındağ F. 2025. Effect of Hesperidin on Lipid Profile, Inflammation and Apoptosis in Experimental Diabetes. Doklady Biochemistry and Biophysics 521:198−205

doi: 10.1134/S1607672924601215
[10]

Shi TF, Zhou Z, Jiang WJ, Huang TL, Si JQ, et al. 2024. Hyperglycemia-induced oxidative stress exacerbates mitochondrial apoptosis damage to cochlear stria vascularis pericytes via the ROS-mediated Bcl-2/CytC/AIF pathway. Redox Report 29:2382943

doi: 10.1080/13510002.2024.2382943
[11]

Chen S, Sun D, Zhang S, Xu L, Wang N, et al. 2024. TIN2 modulates FOXO1 mitochondrial shuttling to enhance oxidative stress-induced apoptosis in retinal pigment epithelium under hyperglycemia. Cell Death & Differentiation 31:1487−1505

doi: 10.1038/s41418-024-01349-8
[12]

Çiğ E, Yardımcı M, Çınar R, Yıldızhan K. 2026. Protective role of zingerone against high glucose-Induced retinal pigment epithelial cell damage through modulation of the TRPM2 channel pathway. Molecular Biology Reports 53:309

doi: 10.1007/s11033-026-11476-9
[13]

Jelinek HF, Helf C, Khalaf K. 2021. Human SHC-transforming protein 1 and its isoforms p66shc: a novel marker for prediabetes. Journal of Diabetes Investigation 12:1881−1889

doi: 10.1111/jdi.13551
[14]

Liang Y, Lei Y, Du M, Liang M, Liu Z, et al. 2021. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: integrative analysis of clinical and bioinformatics databases. Journal of Cellular and Molecular Medicine 25:7039−7051

doi: 10.1111/jcmm.16717
[15]

Tatangelo V, Boncompagni G, Capitani N, Lopresti L, Manganaro N, et al. 2022. p66Shc deficiency in chronic lymphocytic leukemia promotes chemokine receptor expression through the ROS-dependent inhibition of NF-κB. Frontiers in Oncology 12:877495

doi: 10.3389/fonc.2022.877495
[16]

Lebiedzinska-Arciszewska M, Pakula B, Bonora M, Missiroli S, Potes Y, et al. 2024. Distribution of the p66Shc adaptor protein among mitochondrial and mitochondria—associated membranes fractions in normal and oxidative stress conditions. International Journal of Molecular Sciences 25:12835

doi: 10.3390/ijms252312835
[17]

Zhao MH, Hu J, Li S, Wu Q, Lu P. 2018. p66Shc expression in diabetic rat retina. BMC Ophthalmology 18:58

doi: 10.1186/s12886-018-0724-3
[18]

Mishra M, Duraisamy AJ, Bhattacharjee S, Kowluru RA. 2019. Adaptor protein p66Shc: a link between cytosolic and mitochondrial dysfunction in the development of diabetic retinopathy. Antioxidants & Redox Signaling 30:1621−1634

doi: 10.1089/ars.2018.7542
[19]

Shen C, Jiang Y, Lin J, He Y, Liu Y, et al. 2023. SIRT6 reduces the symptoms of premature ovarian failure and alleviates oxidative stress and apoptosis in granulosa cells by degrading p66SHC via H3K9AC. Gynecological Endocrinology 39:2250003

doi: 10.1080/09513590.2023.2250003
[20]

Wu RF, Liao C, Fu G, Hayenga HN, Yang K, et al. 2016. p66Shc couples mechanical signals to RhoA through focal adhesion kinase-dependent recruitment of p115-RhoGEF and GEF-H1. Molecular and Cellular Biology 36:2824−2837

doi: 10.1128/MCB.00194-16
[21]

O'Leary F, Campbell M. 2023. The blood–retina barrier in health and disease. The FEBS Journal 290:878−891

doi: 10.1111/febs.16330
[22]

Dziedziak J, Zaleska-Żmijewska A, Szaflik JP, Cudnoch-Jędrzejewska A. 2022. Impact of arterial hypertension on the eye: a review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Medical Science Monitor 28:e935135

doi: 10.12659/MSM.935135
[23]

Li Y, Chen Q, Liu Y, Bi L, Jin L, et al. 2022. High glucose-induced ROS-accumulation in embryo-larval stages of zebrafish leads to mitochondria-mediated apoptosis. Apoptosis 27:509−520

doi: 10.1007/s10495-022-01731-2
[24]

Gao X, Fan X, Yu X, Wang R, Zhang B, et al. 2025. p66shc exacerbates the progression of obstructive nephropathy through apoptosis, mitochondrial damage, and EMT. Journal of Pediatric Urology 21:834−843

doi: 10.1016/j.jpurol.2025.03.017
[25]

Biondi G, Marrano N, Borrelli A, Rella M, D'Oria R, et al. 2024. The p66Shc redox protein and the emerging complications of diabetes. International Journal of Molecular Sciences 25:108

doi: 10.3390/ijms25010108
[26]

ALTamimi JZ, AlFaris NA, AL-Farga AM, Alshammari GM, BinMowyna MN, et al. 2021. Curcumin reverses diabetic nephropathy in streptozotocin-induced diabetes in rats by inhibition of PKCβ/p66Shc axis and activation of FOXO-3a. The Journal of Nutritional Biochemistry 87:108515

doi: 10.1016/j.jnutbio.2020.108515
[27]

Mengozzi A, Costantino S, Paneni F, Duranti E, Nannipieri M, et al. 2022. Targeting SIRT1 rescues age- and obesity-induced microvascular dysfunction in ex vivo human vessels. Circulation Research 131:476−491

doi: 10.1161/CIRCRESAHA.122.320888
[28]

Kumar S, Kim YR, Vikram A, Naqvi A, Li Q, et al. 2017. Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction. Proceedings of the National Academy of Sciences of the United States of America 114:1714−1719

doi: 10.1073/pnas.1614112114
[29]

Al Sabaani N. 2021. Exendin-4 inhibits high glucose-induced oxidative stress in retinal pigment epithelial cells by modulating the expression and activation of p66Shc. Cutaneous and Ocular Toxicology 40:175−186

doi: 10.1080/15569527.2020.1844727
[30]

Sha Z, Yang Y, Liu R, Bao H, Song S, et al. 2022. Hepatic ischemia-reperfusion injury in mice was alleviated by rac1 inhibition – more than just ROS-inhibition. Journal of Clinical and Translational Hepatology 10:42−52

doi: 10.14218/JCTH.2021.00057
[31]

Wang Z, Xia P, Hu J, Huang Y, Zhang F, et al. 2021. LncRNA MEG3 alleviates diabetic cognitive impairments by reducing mitochondrial-derived apoptosis through promotion of FUNDC1-related mitophagy via Rac1-ROS axis. ACS Chemical Neuroscience 12:2280−2307

doi: 10.1021/acschemneuro.0c00682
[32]

Ji L, Zhang X, Chen Z, Wang Y, Zhu H, et al. 2024. High glucose-induced p66Shc mitochondrial translocation regulates autophagy initiation and autophagosome formation in syncytiotrophoblast and extravillous trophoblast. Cell Communication and Signaling 22:234

doi: 10.1186/s12964-024-01621-x
[33]

Zhu L, Huang R, Feng JR, Zhang M, Huang XJ, et al. 2025. Shexiang Tongxin Dropping Pills attenuate ischemic microvascular dysfunction via suppressing P66Shc-mediated mitochondrial respiration deficits. Journal of Ethnopharmacology 346:119664

doi: 10.1016/j.jep.2025.119664
[34]

Onnis A, Cianfanelli V, Cassioli C, Samardzic D, Pelicci PG, et al. 2018. The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II. Autophagy 14:2117−2138

doi: 10.1080/15548627.2018.1505153
[35]

Reed DK, Carter A, Dixit M, Arany I. 2017. p66shc-mediated toxicity of high-dose α-tocopherol in renal proximal tubule cells. Journal of Physiology and Biochemistry 73:267−273

doi: 10.1007/s13105-017-0551-7
[36]

Zhang M, Yang J, Ji K, He X, He T, et al. 2022. Inhibition of p66Shc attenuates retinal ischemia-reperfusion injury-induced damage by activating the Akt pathway. Experimental Eye Research 220:109082

doi: 10.1016/j.exer.2022.109082
[37]

Mukerjee S, Gonzalez-Reymundez A, Lunt SY, Vazquez AI. 2020. DNA methylation and gene expression with clinical covariates explain variation in aggressiveness and survival of pancreatic cancer patients. Cancer Investigation 38:502−506

doi: 10.1080/07357907.2020.1812079
[38]

Bashir M, Kirmani D, Bhat HF, Baba RA, Hamza R, et al. 2010. P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Cell Communication and Signaling 8:13

doi: 10.1186/1478-811X-8-13
[39]

Park YJ, Lee YJ, Kim SH, Joung DS, Kim BJ, et al. 2008. Ghrelin enhances the proliferating effect of thyroid stimulating hormone in FRTL-5 thyroid cells. Molecular and Cellular Endocrinology 285:19−25

doi: 10.1016/j.mce.2008.01.003
[40]

Patrussi L, Capitani N, Baldari CT. 2020. P66Shc: a pleiotropic regulator of B cell trafficking and a gatekeeper in chronic lymphocytic leukemia. Cancers 12:1006

doi: 10.3390/cancers12041006